Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Average EV/EBIT Ratio

EV/EBIT Ratio

The current ev/ebit ratio for Intuitive Surgical, Inc. (ISRG) is 45.56x as of Wednesday, June 10, 2026, shown against its trailing averages.

Average EV/EBIT Ratio Chart

ISRG EV/EBIT Ratio Averages

EV/EBIT RATIO CURRENT

45.56x

EV/EBIT RATIO TTM

63.25x

EV/EBIT RATIO 3Y

73.01x

EV/EBIT RATIO 5Y

67.77x

EV/EBIT RATIO 10Y

57.96x

EV/EBIT RATIO 15Y

46.63x

EV/EBIT RATIO 20Y

43.82x

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa